Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(3.92)
# 647
Out of 5,006 analysts
387
Total ratings
41.9%
Success rate
13.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $24.48 | +104.25% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $4.01 | +199.25% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $452.00 | +26.11% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $6.29 | +535.93% | 17 | Aug 4, 2025 | |
| ATAI Atai Life Sciences | Maintains: Buy | $10 → $15 | $5.47 | +174.22% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $6.54 | +52.91% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.42 | +252.11% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.70 | +1,330.62% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.19 | +1,345.09% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $34.01 | +194.03% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $52.91 | +32.30% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.36 | +267.65% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.67 | +958.20% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $37.50 | +113.33% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $13.06 | +206.28% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.95 | +506.06% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $26.59 | +163.26% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $25.89 | +209.00% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $2.12 | +371.70% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.41 | +314.94% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $12.22 | +350.08% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $5.59 | +1,867.80% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $51.50 | +65.05% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $6.43 | +2,232.81% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $13.66 | +397.80% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $188.66 | +80.22% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $24.48
Upside: +104.25%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $4.01
Upside: +199.25%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $452.00
Upside: +26.11%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $6.29
Upside: +535.93%
Atai Life Sciences
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $5.47
Upside: +174.22%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $6.54
Upside: +52.91%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.42
Upside: +252.11%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.70
Upside: +1,330.62%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $5.19
Upside: +1,345.09%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $34.01
Upside: +194.03%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $52.91
Upside: +32.30%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.36
Upside: +267.65%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $5.67
Upside: +958.20%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $37.50
Upside: +113.33%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $13.06
Upside: +206.28%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.95
Upside: +506.06%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $26.59
Upside: +163.26%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $25.89
Upside: +209.00%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $2.12
Upside: +371.70%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $2.41
Upside: +314.94%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $12.22
Upside: +350.08%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $5.59
Upside: +1,867.80%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $51.50
Upside: +65.05%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $6.43
Upside: +2,232.81%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $13.66
Upside: +397.80%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $188.66
Upside: +80.22%